X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (226) 226
Book Review (55) 55
Publication (34) 34
Book Chapter (23) 23
Conference Proceeding (23) 23
Book / eBook (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (131) 131
humans (130) 130
female (125) 125
oncology (116) 116
obstetrics & gynecology (76) 76
cancer (68) 68
chemotherapy (52) 52
adult (50) 50
middle aged (46) 46
cervical cancer (41) 41
ovarian cancer (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (38) 38
aged (37) 37
carcinoma (35) 35
bevacizumab (34) 34
obstetrics and gynecology (33) 33
neoplasm staging (30) 30
hematology, oncology and palliative medicine (29) 29
uterine cervical neoplasms - drug therapy (29) 29
uterine cervical neoplasms - pathology (29) 29
article (28) 28
care and treatment (26) 26
abridged index medicus (25) 25
aged, 80 and over (25) 25
ovarian neoplasms - drug therapy (24) 24
treatment outcome (24) 24
disease-free survival (22) 22
ovarian neoplasms - pathology (21) 21
survival (21) 21
cisplatin (20) 20
gynecologic-oncology-group (20) 20
neoplasm recurrence, local - drug therapy (20) 20
prognosis (20) 20
squamous-cell carcinoma (20) 20
pregnancy (19) 19
angiogenesis (18) 18
clinical trials (18) 18
analysis (17) 17
angiogenesis inhibitors - therapeutic use (17) 17
paclitaxel - administration & dosage (17) 17
phase-ii trial (17) 17
uterine cervix (17) 17
health aspects (15) 15
research (15) 15
women (15) 15
endometrial cancer (14) 14
paclitaxel (14) 14
therapy (14) 14
carcinoma, ovarian epithelial (13) 13
cisplatin - administration & dosage (13) 13
phase-iii trial (13) 13
pregnant women (13) 13
survival analysis (13) 13
survival rate (13) 13
uterine cervical neoplasms - therapy (13) 13
endothelial growth-factor (12) 12
medicine and health sciences (12) 12
ovarian neoplasms - surgery (12) 12
radiotherapy (12) 12
antineoplastic agents - therapeutic use (11) 11
brachytherapy (11) 11
oncology, experimental (11) 11
pharmacology & pharmacy (11) 11
uterine cervical neoplasms - mortality (11) 11
double-blind (10) 10
drug therapy (10) 10
management (10) 10
metastasis (10) 10
ovarian neoplasms - therapy (10) 10
quality of life (10) 10
randomized controlled trials as topic (10) 10
randomized-trial (10) 10
retrospective studies (10) 10
bevacizumab - therapeutic use (9) 9
chemotherapy, adjuvant (9) 9
open-label (9) 9
ovarian neoplasms - mortality (9) 9
surgery (9) 9
trial (9) 9
uterine cervical neoplasms - radiotherapy (9) 9
animals (8) 8
antineoplastic agents - administration & dosage (8) 8
breast-cancer (8) 8
cancer therapies (8) 8
carboplatin (8) 8
carboplatin - administration & dosage (8) 8
clinical trials, phase ii as topic (8) 8
clinical trials, phase iii as topic (8) 8
combined modality therapy (8) 8
neoplasm metastasis (8) 8
neoplasm recurrence, local (8) 8
neoplasms, glandular and epithelial - drug therapy (8) 8
ovarian neoplasms - genetics (8) 8
patient outcomes (8) 8
peritoneal neoplasms - drug therapy (8) 8
radiation-therapy (8) 8
recurrent (8) 8
review (8) 8
tumor angiogenesis (8) 8
antimitotic agents (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015, ISBN 9783319080666
A thorough review on ovarian cancer, treatment guidelines and emerging therapies available for the disease. The book was originally commissioned due to recent... 
Medicine | Toxicology | Pharmacy | Gynecology | Oncology
Web Resource
2015, ISBN 9783319080666
A thorough review on ovarian cancer, treatment guidelines and emerging therapies available for the disease. The book was originally commissioned due to recent... 
Medicine | Toxicology | Pharmacy | Gynecology | Oncology
Web Resource
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 06/2019, Volume 37, Issue 17, pp. 1449 - 1449
A 36-year-old white married mother of two small children presented with intermenstrual bleeding, dyspareunia, and pelvic pain. Because of significant lapses in... 
PHASE-III TRIAL | UTERINE CERVIX | QUADRIVALENT VACCINE | 9-VALENT HPV VACCINE | ANGIOGENESIS BLOCKADE | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RANDOMIZED-TRIAL | OPEN-LABEL | HUMAN-PAPILLOMAVIRUS | CANCER
Journal Article
2015, 2015, ISBN 9783319080659, 209
A thorough review on ovarian cancer, treatment guidelines and emerging therapies available for the disease. The book was originally commissioned due to recent... 
Clinical & internal medicine | Ovaries | Cancer | Medicine & Public Health | Oncology
eBook
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 734 - 743
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 779 - 791
Journal Article
Journal of Gynecologic Oncology (JGO), ISSN 2005-0380, 2017, Volume 28, Issue 5, p. 1
Journal Article
2012, 8th ed., ISBN 0323074197, xii, 708
Clinical Gynecologic Oncology, by Drs. Di Saia and Creasman, is the leading medical reference book geared toward helping you improve gynecologic cancer... 
Genital Neoplasms, Female
Book
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 25, pp. 2687 - 2690
Journal Article
Recent patents on biotechnology, 11/2017
Fully humanized monoclonal antibodies have revolutionized the treatment of many solid tumors, including breast, lung, colorectal, and ovarian cancer. Among the... 
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 386 - 391
Abstract Background Veliparib is a potent small molecule inhibitor of PARP-1/2, which is cytotoxic in tumor cells with deficiencies in BRCA1 or BRCA2 . We... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | BRCA1, BRCA2 mutation | Toxicity | Veliparib | PARP inhibitor | Phase II trial | Ovarian cancer | SENSITIVITY | OPEN-LABEL | COMBINATION | PLATINUM-FREE INTERVAL | SOMATIC MUTATIONS | OBSTETRICS & GYNECOLOGY | OLAPARIB | ONCOLOGY | RESISTANCE | HOMOLOGOUS RECOMBINATION | REFRACTORY SOLID TUMORS | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Peritoneal Neoplasms - genetics | Fallopian Tube Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Aged, 80 and over | Carcinoma, Ovarian Epithelial | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Genes, BRCA1 | Benzimidazoles - adverse effects | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Benzimidazoles - therapeutic use | Fallopian Tube Neoplasms - drug therapy | Medical research | Cancer patients | Care and treatment | Gene mutations | Analysis | Medicine, Experimental | Genetic aspects | Cancer | Chemotherapy | Clinical trials | Index Medicus | toxicity | BRCA2 mutation | ovarian cancer | veliparib | BRCA1
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 11/2011, Volume 123, Issue 2, p. 451
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 301 - 311
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 11/2011, Volume 123, Issue 2, p. 451
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.